New research counts 273,000 jobs and a pharmacy in nearly every community
Medical director at Phoenix and Raven explains why brand-name Ozempic still leads despite Health Canada approvals
The authorization could ease cost pressures on group benefit plan sponsors covering GLP-1 drugs
Researchers call for closer monitoring as smell and taste risks emerge
Single-dose patients faced fewer side effects and clinic visits with no loss in outcomes
The drug works alongside a reduced-calorie diet and added physical activity
